Back

Impact of diabetes on 5-year clinical outcomes in stable coronary artery disease, across multiple geographical regions and ethnicities. Insights from the CLARIFY registry

26 August 2018 (17:25 - 17:35)
Organised by:
Congress Presentation Part of: There is no sweet spot in diabetes Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Koon-Hou Mak

Mak Heart Clinic, Singapore (Singapore)

5 More presentations in this session

Presentation thumbnail
Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus - The MET-REMODEL trialM
Professor C. Lang (Dundee, GB)
Abstract
Presentation thumbnail
Association between insulin resistance and coronary plaque vulnerability in patients with acute coronary syndromes: insights from optical coherence tomography
Doctor S. Wu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Impact of statin treatment on the prevalence of lesion vulnerability and instability features in patients with diabetes mellitus - Insights from the COMBINE (FFR-OCT) Study
Doctor B. Berta (Kecskemet, HU)
Abstract Slides Video
Presentation thumbnail
Sex differences in mortality and rates of cardiovascular disease in patients with diabetes
Mr M. Malmborg (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Impact of chronic kidney disease on diabetic patients with stable coronary disease undergoing surgery, angioplasty or medical treatment in a ten-year follow-up.
Mr E. Martins (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
There is no sweet spot in diabetes

The Event

Event poster

ESC Congress 2018

26 August 2018 17:25 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources